Dan Segerbäck

3.6k total citations
62 papers, 2.6k citations indexed

About

Dan Segerbäck is a scholar working on Cancer Research, Molecular Biology and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Dan Segerbäck has authored 62 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Cancer Research, 24 papers in Molecular Biology and 14 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Dan Segerbäck's work include Carcinogens and Genotoxicity Assessment (37 papers), DNA Repair Mechanisms (11 papers) and Skin Protection and Aging (8 papers). Dan Segerbäck is often cited by papers focused on Carcinogens and Genotoxicity Assessment (37 papers), DNA Repair Mechanisms (11 papers) and Skin Protection and Aging (8 papers). Dan Segerbäck collaborates with scholars based in Sweden, Germany and United Kingdom. Dan Segerbäck's co-authors include Siv Osterman-Golkar, L. Ehrenberg, Carl Johan Calleman, Inger Porsch Hällström, Kettil Svensson, Vladimir J.N. Bykov, Jérémy Lambert, Jan Bergman, Klas G. Wiman and Alan R. Fersht and has published in prestigious journals such as Cancer Cell, Oncogene and Biochemical and Biophysical Research Communications.

In The Last Decade

Dan Segerbäck

61 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dan Segerbäck Sweden 25 1.3k 958 719 448 399 62 2.6k
F.T. Hatch United States 26 1.3k 1.0× 989 1.0× 444 0.6× 371 0.8× 383 1.0× 52 2.5k
Leslie Recio United States 32 1.7k 1.4× 1.5k 1.5× 805 1.1× 522 1.2× 321 0.8× 110 3.0k
Judson W. Spalding United States 28 1.5k 1.2× 1.4k 1.5× 721 1.0× 453 1.0× 142 0.4× 67 3.2k
Thomas L. Goldsworthy United States 38 1.7k 1.3× 1.6k 1.7× 934 1.3× 216 0.5× 202 0.5× 87 4.1k
Siv Osterman-Golkar Sweden 34 2.2k 1.8× 1.1k 1.2× 1.3k 1.7× 646 1.4× 345 0.9× 89 3.5k
James S. Felton United States 20 891 0.7× 647 0.7× 472 0.7× 108 0.2× 140 0.4× 37 1.9k
Gonçalo Gamboa da Costa United States 28 446 0.4× 659 0.7× 458 0.6× 469 1.0× 768 1.9× 75 2.2k
J.A. Styles United Kingdom 26 1.2k 0.9× 862 0.9× 565 0.8× 374 0.8× 128 0.3× 76 2.4k
Friedrich J. Wiebel Germany 30 873 0.7× 943 1.0× 610 0.8× 184 0.4× 85 0.2× 85 2.6k
Matthew Bryant United States 30 705 0.6× 807 0.8× 640 0.9× 135 0.3× 152 0.4× 76 2.5k

Countries citing papers authored by Dan Segerbäck

Since Specialization
Citations

This map shows the geographic impact of Dan Segerbäck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Segerbäck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Segerbäck more than expected).

Fields of papers citing papers by Dan Segerbäck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Segerbäck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Segerbäck. The network helps show where Dan Segerbäck may publish in the future.

Co-authorship network of co-authors of Dan Segerbäck

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Segerbäck. A scholar is included among the top collaborators of Dan Segerbäck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Segerbäck. Dan Segerbäck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Narbutt, Joanna, Peter A. Philipsen, Aleksandra Lesiak, et al.. (2018). Children sustain high levels of skin DNA photodamage, with a modest increase of serum 25-hydroxyvitamin D3, after a summer holiday in Northern Europe. British Journal of Dermatology. 179(4). 940–950. 15 indexed citations
2.
Petersen, B., Hans Christian Wulf, Margarita Triguero‐Mas, et al.. (2014). Sun and Ski Holidays Improve Vitamin D Status, but Are Associated with High Levels of DNA Damage. Journal of Investigative Dermatology. 134(11). 2806–2813. 65 indexed citations
3.
4.
Singh, Rajinder, Jolanta Gromadzińska, Yogita Mistry, et al.. (2012). Detection of acetaldehyde derived N2-ethyl-2′-deoxyguanosine in human leukocyte DNA following alcohol consumption. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 737(1-2). 8–11. 21 indexed citations
5.
Lambert, Jérémy, Dmitry B. Veprintsev, Dan Segerbäck, et al.. (2009). PRIMA-1 Reactivates Mutant p53 by Covalent Binding to the Core Domain. Cancer Cell. 15(5). 376–388. 450 indexed citations
6.
Heikkinen, Aki T., et al.. (2009). Transplacental Transfer of Nitrosodimethylamine in Perfused Human Placenta. Placenta. 30(3). 277–283. 29 indexed citations
7.
Emeny, J. M., Johan Hansson, Rune Toftgård, & Dan Segerbäck. (2008). Meeting Report of the Conference on UV-Radiation-Induced Disease—Roles of UVA and UVB. Journal of Investigative Dermatology. 128(8). 1875–1877. 1 indexed citations
8.
Karttunen, Vesa, Pekka Keski‐Rahkonen, P Myllynen, et al.. (2008). Transplacental transfer of acrylamide and glycidamide are comparable to that of antipyrine in perfused human placenta. Toxicology Letters. 182(1-3). 50–56. 61 indexed citations
9.
Osterman-Golkar, Siv, Kamila Czene, Thomas Faller, et al.. (2003). Dosimetry by means of DNA and hemoglobin adducts in propylene oxide-exposed rats. Toxicology and Applied Pharmacology. 191(3). 245–254. 19 indexed citations
10.
Plná, Kamila, Thomas Faller, Winfried Kessler, et al.. (1997). Propylene oxide: mutagenesis, carcinogenesis and molecular dose. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 380(1-2). 179–197. 29 indexed citations
11.
Plná, Kamila, Dan Segerbäck, & Elke K. H. Schweda. (1996). CARCINOGENESIS: DNA adduct formation by allyl glycidyl ether. Carcinogenesis. 17(7). 1465–1471. 14 indexed citations
12.
Segerbäck, Dan, Carl Johan Calleman, Jesara L. Schroeder, Lucio G. Costa, & Elaine M. Faustman. (1995). Formation of N-7-(2-carbamoyl-2-hydroxyethyl)guanine in DNA of the mouse and the rat following intraperitoneal administration of [14C]acrylamide. Carcinogenesis. 16(5). 1161–1165. 189 indexed citations
13.
Segerbäck, Dan, et al.. (1994). Comparative two-stage cancer tests of ethylene oxide, N-(2-hydroxyethyl)-N-nitrosourea and X-rays. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 307(1). 387–393. 8 indexed citations
14.
Hemminki, Kari, et al.. (1994). DNA adducts among personnel servicing and loading diesel vehicles. Carcinogenesis. 15(4). 767–769. 43 indexed citations
15.
Segerbäck, Dan & Pavel Vodička. (1993). Recoveries of DNA adducts of polycyclic aromatic hydrocarbons in the 32P-postlabelling assay. Carcinogenesis. 14(12). 2463–2469. 23 indexed citations
16.
Segerbäck, Dan & Fred F. Kadlubar. (1992). Characterization of 4,4′-methylenebis(2-chloroaniline)—DNA adducts formed in vivo and in vitro. Carcinogenesis. 13(9). 1587–1592. 12 indexed citations
17.
Segerbäck, Dan. (1990). Reaction products in hemoglobin and DNA after in vitro treatment with ethylene oxide and N-(2-hydroxyethyl)-N-nitrosourea. Carcinogenesis. 11(2). 307–312. 84 indexed citations
18.
Segerbäck, Dan, Carl Johan Calleman, L. Ehrenberg, Göran Löfroth, & Siv Osterman-Golkar. (1978). Evaluation of genetic risks of alkylating agents IV. Quantitative determination of alkylated amino acids in haemoglobin as a measure of the dose after treatment of mice with methyl methanesulfonate. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 49(1). 71–82. 67 indexed citations
19.
Ehrenberg, L., Siv Osterman-Golkar, Dan Segerbäck, Kettil Svensson, & Carl Johan Calleman. (1977). Evaluation of genetic risks of alkylating agents. III. Alkylation of haemoglobin after metabolic conversion of ethene to ethene oxide in vivo. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 45(2). 175–184. 89 indexed citations
20.
Osterman-Golkar, Siv, L. Ehrenberg, Dan Segerbäck, & Inger Porsch Hällström. (1976). Evaluation of genetic risks of alkylating agents. II. Haemoglobin as a dose monitor. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 34(1). 1–10. 210 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026